Tyce Gm
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 3
-
- Diet and metabolism studies 2
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 3
-
- Attention Deficit Hyperactivity Disorder 1
-
- Metabolism and Genetic Disorders 3
-
- Receptor Mechanisms and Signaling 2
-
- Veterinary Pharmacology and Anesthesia 2
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- MuenterDonna L. HammondOwen CaFústerShepherd JtVanhoutte Pmvan Heerden JaRichard W. Bianco
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (16 papers)
- Partner nations
- United States
In The Last Decade
Tyce Gm
16 papers receiving 509 citations
Peers
Comparison fields: 5 of 62
- Neurology 388
- Cellular and Molecular Neuroscience 213
- Physiology 102
- Neurology 26
- Psychiatry and Mental health 38
Countries citing papers authored by Tyce Gm
This map shows the geographic impact of Tyce Gm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyce Gm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyce Gm more than expected).
Fields of papers citing papers by Tyce Gm
This network shows the impact of papers produced by Tyce Gm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyce Gm. The network helps show where Tyce Gm may publish in the future.
Co-authorship network
The 12 scholars most cited alongside Tyce Gm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats. | 1989 | 2 |
| 2 | Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. | 1989 | 17 |
| 3 | High energy phosphates and catecholamine stores after prolonged ex vivo heart preservation. | 1987 | 4 |
| 4 | Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information. | 1981 | 76 |
| 5 | Release of norepinephrine and serotonin in cat spinal cord: direct in vivo evidence for the activation of descending monoamine pathways by somatic stimulation. | 1981 | 16 |
| 6 | Dipyridamole levels in plasma of man and other species. | 1979 | 13 |
| 7 | Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors. | 1978 | 14 |
| 8 | The carcinoid syndrome--a role for hemodialysis. | 1977 | 1 |
| 9 | Demethylation of O-methyl metabolites of catecholamines in erythrocytes: a methanol-forming reaction. | 1977 | 1 |
| 10 | Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease. | 1977 | 119 |
| 11 | Demethylation of 3-methoxy-4-hydroxyphenylalanine in the isolated perfused rat liver. | 1974 | 1 |
| 12 | 3-O-Methyldopa in Parkinson's disease. | 1974 | 16 |
| 13 | 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. | 1973 | 23 |
| 14 | Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease. | 1972 | 17 |
| 15 | L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. | 1971 | 207 |
| 16 | Dihydroxyphenylalanine (DOPA) in plasma during dopa treatment of patients with Parkinson's disease. | 1970 | 13 |
| 17 | Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease. | 1970 | 9 |
About Tyce Gm
Tyce Gm is a scholar working on Clinical Biochemistry, Neurology, Small Animals, Cellular and Molecular Neuroscience and Pharmaceutical Science, having authored 17 papers that have together received 549 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Metabolism and Genetic Disorders (3 papers), Neurological disorders and treatments (3 papers), Receptor Mechanisms and Signaling (2 papers), Diet and metabolism studies (2 papers), Veterinary Pharmacology and Anesthesia (2 papers), Attention Deficit Hyperactivity Disorder (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Neurology (388 citations), Cellular and Molecular Neuroscience (213 citations), Physiology (102 citations), Neurology (26 citations) and Psychiatry and Mental health (38 citations). Tyce Gm has collaborated with scholars based in United States. Frequent co-authors include Muenter, Donna L. Hammond, Owen Ca, Fúster, Shepherd Jt, Vanhoutte Pm, van Heerden Ja, Richard W. Bianco, Kaye Mp and Ernesto Solis. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.